Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022104 (
irritable bowel syndrome
)
8,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Myocardial involvement is a common finding in certain myopathies, while it has not been extensively investigated in
facioscapulohumeral muscular dystrophy
(
FSHD1A
). Aim of this study was to assess in
FSHD1A
patients the electrical and functional properties of the myocardium. Twenty-four patients with
FSHD1A
(mean age 41.2+/-14.5 years) and 24 matched healthy subjects were studied. Standard- and signal-averaged electrocardiography were recorded to determine QT dispersion and the presence of ventricular late potentials (VLPs). Standard echocardiography with systo-diastolic variations of integrated backscatter signal (CV-
IBS
) were performed to assess functional properties of the myocardium. Compared with control subjects, patients with
FSHD1A
had significantly lower CV-
IBS
and higher QT dispersion. Nine patients had positive VLPs. QT and QTc dispersion were inversely related to CV-
IBS
at both septum and posterior wall levels. Moreover, septal CV-
IBS
was inversely related to the Kpnl-BinI4q fragment size. These results suggest a subclinical cardiac involvement in
FSHD1A
patients, which can represent a substrate for ventricular arrhythmias and heart failure.
...
PMID:Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy. 1636 38